TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome-Reference-Cited by-同舟云学术

TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome

Published:2022-02-01 Issue:1 Volume:35 Page:15-23
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Naghib Maryam¹,Kariminik Ashraf¹^ORCID,Kazemi Arababadi Mohammad²³

Affiliation:

1. Department of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran.

2. Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

3. Department of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2021.0141

Reference103 articles.

1. The IL-10 Promoter Polymorphism at Position −592 is Correlated with Susceptibility to Occult HBV Infection

2. Toll-like receptor 2 and its roles in immune responses against Legionella pneumophila

3. Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B

4. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of IL-9 Cytokines with Hepatic Injury in Echinococcus granulosus Infection;Biomolecules;2024-08-14

2. Toll-like receptors and Streptococcus mutans: An updated review article;Allergologia et Immunopathologia;2024-01-01

3. Identification of molecular signatures in acute myocardial infarction based on integrative analysis of proteomics and transcriptomics;Genomics;2023-09

4. Comparative analyses of bat genomes identify distinct evolution of immunity in Old World fruit bats;Science Advances;2023-05-05

5. The progress of molecules and strategies for the treatment of HBV infection;Frontiers in Cellular and Infection Microbiology;2023-03-15